Cargando…
Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain
BACKGROUND: Osteoarthritis (OA) causes substantial pain and reduced health-related quality of life (HRQL). Although opioid analgesics are commonly used, the relative benefits of different opioids are poorly studied. Transdermal buprenorphine (TDB) offers an alternative to oral opioids for the treatm...
Autores principales: | Conaghan, Philip G., Serpell, Michael, McSkimming, Paula, Junor, Rod, Dickerson, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925685/ https://www.ncbi.nlm.nih.gov/pubmed/27314487 http://dx.doi.org/10.1007/s40271-016-0181-0 |
Ejemplares similares
-
Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey
por: Emmanuel, Anton, et al.
Publicado: (2017) -
Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study
por: Serpell, Mick, et al.
Publicado: (2015) -
Pharmacokinetics of transdermal buprenorphine patch in the elderly
por: Al-Tawil, Nabil, et al.
Publicado: (2012) -
Transdermal buprenorphine for pain management in children
por: Attinà, Giorgio, et al.
Publicado: (2021) -
The feasibility of a randomised controlled trial to compare the
cost-effectiveness of palliative cardiology or usual care in people with
advanced heart failure: Two exploratory prospective cohorts
por: Johnson, Miriam J, et al.
Publicado: (2018)